An intergenic region on chromosome 13q33.3 is associated with the susceptibility to kidney disease in type 1 and 2 diabetes

Kidney International

Volumn 80, Issue 1, 2011, Pages 105-111

  Pezzolesi, Marcus G ^a,b   Poznik, G David ^a   Skupien, Jan ^a,b   Smiles, Adam M ^a   Mychaleckyj, Josyf C ^c   Rich, Stephen S ^c   Warram, James H ^a   Krolewski, Andrzej S ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

diabetic nephropathy; genetic association; type 1 diabetes; type 2 diabetes

Indexed keywords

ADULT; ARTICLE; CHROMOSOME 13Q; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPANESE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PLESIOMORPHY; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79958865808     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.64     Document Type: Article

References (22)

1. Krolewski AS, Warram JH. Clinical features and epidemiology of diabetic nephropathy. In: Pickup JC, Williams G (eds). Textbook of Diabetes, Vol. 2 Blackwell Scientific Publications: Oxford, 1997: 53.1-53.13.
2. Parving HH, Mauer M, Ritz E. Diabetic nephropathy. In: Brenner BM (ed). Brenner and Rector's The Kidney. Elsevier: Philadelphia, 2004: 1777-1818.
3. Jones CA, Krolewski AS, Rogus J et al. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney Int 2005; 67: 1684-1691. (Pubitemid 40577702)
4. Seaquist ER, Goetz FC, Rich S et al. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320: 1161-1165. (Pubitemid 19124296)
5. Borch-Johnsen K, Norgaard K, Hommel E et al. Is diabetic nephropathy an inherited complication? Kidney Int 1992; 41: 719-722.
6. Freedman BI, Tuttle AB, Spray BJ. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1995; 25: 710-713.
7. McCance DR, Hanson RL, Pettitt DJ et al. Diabetic nephropathy: a risk factor for diabetes mellitus in offspring. Diabetologia 1995; 38: 221-226.
8. Quinn M, Angelico MC, Warram JH et al. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996; 39: 940-945. (Pubitemid 26249113)
9. Rich SS. Genetics of diabetes and its complications. J Am Soc Nephrol 2006; 17: 353-360.
10. Pezzolesi MG, Poznik GD, Mychaleckyj JC et al. Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 2009; 58: 1403-1410.
11. Tsaih SW, Pezzolesi MG, Yuan R et al. Genetic analysis of albuminuria in aging mice and concordance with loci for human diabetic nephropathy found in a genome-wide association scan. Kidney Int 2010; 77: 201-210.
12. Maeda S, Araki S, Babazono T et al. Replication study for the association between 4 loci identified by a genome-wide association study on European American subjects with type 1 diabetes, susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes. Diabetes 2010; 59: 2075-2079.
13. Placha G, Canani LH, Warram JH et al. Evidence for different susceptibility genes for proteinuria, ESRD in type 2 diabetes. Adv Chronic Kidney Dis 2005; 12: 155-169. (Pubitemid 40488998)
14. Al-Kateb H, Boright AP, Mirea L et al. Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study. Diabetes 2008; 57: 218-228.
15. Freedman BI, Langefeld CD, Rich SS et al. A genome scan for ESRD in black families enriched for nondiabetic nephropathy. J Am Soc Nephrol 2004; 15: 2719-2727. (Pubitemid 41103379)
16. Freedman BI, Bowden DW, Rich SS et al. A genome scan for all-cause endstage renal disease in African Americans. Nephrol Dial Transplant 2005; 20: 712-718. (Pubitemid 40520647)
17. Pomerantz MM, Ahmadiyeh N, Jia L et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 2009; 41: 882-884.
18. Visel A, Zhu Y, May D et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 2010; 464: 409-412.
19. Dickson SP, Wang K, Krantz I et al. Rare variants create synthetic genomewide associations. PLoS Biol 2010; 8: e1000294.
20. Antonellis A, Green ED. The role of aminoacyl-tRNA synthetases in genetic diseases. Annu Rev Genomics Hum Genet 2008; 9: 87-107.
21. Warram JH, Gearin G, Laffel L et al. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 1996; 7: 930-937. (Pubitemid 27465988)
22. Purcell S, Neale B, Todd-Brown K et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575. (Pubitemid 47330214)